Cytosorbents (CTSO) FCF Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly FCF Margin came in at 6.2% in Q2 2026, up 727.0% on a YoY basis from 0.75% in Q2 2025, and up 53.17% quarter-over-quarter from 13.23% in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) FCF Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported FCF Margin for 16 consecutive years, with 6.2% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 727.0% year-over-year to 6.2%; the trailing twelve-month figure through Jun 2026 stood at 24.98% (up 282.0% YoY), and the FY2025 full-year result was 33.84%, up 749.0% from the prior year.
- FCF Margin grew to 6.2% in Q2 2026 per CTSO's latest filing, from 13.23% in the prior quarter.
- Across five years, FCF Margin topped out at 6.2% in Q2 2026 and bottomed at 131.11% in Q2 2022.
- Historically, FCF Margin has averaged 53.68% across 5 years, with a median of 53.83% in 2025.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 10762 bps in 2022, then jumped 7970 bps in 2023.
- Over 5 years, FCF Margin stood at 59.14% in 2022, then retreated by 27 bps to 75.02% in 2023, then surged by 65 bps to 26.34% in 2024, then plunged by 103 bps to 53.42% in 2025, then soared by 88 bps to 6.2% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 6.2%, 13.23%, and 53.42% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.73% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -6.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.20% |
| Mar 31, 2026 | -13.23% |
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | -27.35% |
| Jun 30, 2025 | -13.47% |
| Mar 31, 2025 | -42.61% |
| Dec 31, 2024 | -26.34% |
| Sep 30, 2024 | -30.36% |
| Jun 30, 2024 | -54.42% |
| Mar 31, 2024 | -54.23% |
| Dec 31, 2023 | -75.02% |
| Sep 30, 2023 | -60.71% |
| Jun 30, 2023 | -71.37% |
| Mar 31, 2023 | -38.29% |
| Dec 31, 2022 | -59.14% |
| Sep 30, 2022 | -90.92% |
| Jun 30, 2022 | -131.11% |
| Mar 31, 2022 | -117.99% |
| Dec 31, 2021 | -65.14% |
| Sep 30, 2021 | -51.48% |